MNKD vs VRTX: Which Stock is Better?
Side-by-side comparison of MannKind Corp and Vertex Pharmaceuticals Inc in 2026
MNKD
MannKind Corp
$5.49
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | MNKD | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.56B | $113.35B | VRTX |
| P/E Ratio | 50.70 | 31.15 | VRTX |
| EPS (TTM) | $0.10 | $14.19 | VRTX |
| Revenue Growth | 0.2% | 0.1% | MNKD |
| Gross Margin | 75.2% | 52.7% | MNKD |
Analyze MNKD
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MNKD or VRTX a better investment?
Comparing MNKD and VRTX: MannKind Corp has a market cap of $1.56B while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MNKD and VRTX?
MNKD (MannKind Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MNKD or VRTX?
Based on P/E ratios, VRTX trades at a lower multiple (31.2x vs 50.7x).
Which is growing faster: MNKD or VRTX?
MNKD has higher revenue growth at 0.2% vs 0.1% for VRTX.
Which company is more profitable: MNKD or VRTX?
MannKind Corp (MNKD) has higher gross margins at 75.2% compared to 52.7% for VRTX.
Which is the larger company: MNKD or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $1.56B for MNKD.
Should I buy MNKD or VRTX in 2026?
Both MNKD and VRTX have investment merit. MNKD trades at $5.49 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MNKD and VRTX stock?
Key differences: Market Cap ($1.56B vs $113.35B), P/E Ratio (50.7x vs 31.2x), Revenue Growth (0.2% vs 0.1%), Gross Margin (75.2% vs 52.7%).